Krankenhaus Der Barmherzigen Schwestern Wien Betriebsgesellschaft mbH — Clinical Trial Site

12 Registered trials

5 Currently recruiting

Organisation

Krankenhaus Der Barmherzigen Schwestern Wien Betriebsgesellschaft mbH

Location

Linz, Austria

Identifier

ORG-100030824

Address

Stumpergasse 13, Mariahilf, 1060, Austria

Departments

1. Med. Abteilung, Onkologie und Hämatologie
Abt. Gynäkologie und Geburtshilfe
Abteilung für Radioonkologie und Strahlentherapie
Betriebsgesellschaft m.b.H.
Department of Ear, Nose and Throat Diseases
Department of Internal Medicine
I. Medizinischen Abteilung - Onkologie & Hämatologie
Internal Medicine
Interne I
Klinik für Hämatologie und Onkologie
Onkologie/ Interne Medizin
Visceral Oncology Center

Clinical trials at this site (12)

Search interface

Study to Investigate the Efficacy, Safety, and Tolerability of Intravenous Gammagard Liquid (Immune Globulin Infusion, 10%) for Primary Infe… Pending

2024-518420-80-00 Primary infection prophylaxis for secondary immunodefic 5
A phase II, double-blind, randomised, placebo-controlled trial to evaluate the efficacy and tolerability of a rectal treatment with budesoni… Recruiting

2024-519359-27-00 Acute radiation proctitis symptoms in male patients age 4 2026-04-16
A phase 1 study of FluBHPVE6E7 immunotherapy in patients with HPV16-associated oropharyngeal squamous cell carcinoma Recruiting

2024-514413-36-00 Treatment of human papilloma virus (HPV) associated inf 3 2024-04-29
MAintenance Therapy with Aromatase inhibitor in epithelial Ovarian cancer Recruiting

2024-511219-78-00 epithelial ovarian cancer 5 2023-02-28
MagnetisMM-6: A Phase 3 Study of Elranatamab (PF-06863135) + Daratumumab + Lenalidomide Versus Daratumumab + Bortezomib + Lenalidomide + Dex… Recruiting

2024-514139-50-00 Multiple myeloma 5 2022-11-14
Effect of high-dose vitamin D on 28-day mortality in adult critically ill patients with severe vitamin D deficiency Recruiting

2024-514556-32-00 Adult critically ill patients with severe vitamin D def 5 2017-02-15
Phase 3 Study to Evaluate Mezigdomide (CC-92480/BMS-986348) in Combination with Carfilzomib and Dexamethasone in Relapsed or Refractory Mult… Ended

2022-500861-29-00 Relapsed or Refractory Multiple Myeloma (RRMM) 5 2023-01-12
Isatuximab in combination with Lenalidomide-Dexamethasone compared to Lenalidomide-Dexamethasone in elderly patients (aged ≥70 years) with n… Ended

2024-515581-13-00 Isatuximab in combination with Lenalidomide-Dexamethaso 4 2021-10-20
Study to compare overall survival (OS) between subjects who receive SBP-101 and those who do not receive SBP-101 (i.e., placebo) in combinat… Ended

2024-514714-12-00 Metastatic Pancreatic Ductal Adenocarcinoma 10 2022-11-11
CIRCULATE Ended

2023-506715-18-00 colon cancer stage II, rectal cancer stage II 5 2019-12-04
Nivo versus Nivo/Ipi or versus other chemotherapies to treat colorectal cancer Ended

2023-503956-29-00 Microsatellite Instability High (MSI-H) or Mismatch Rep 5 2019-08-26
Ramucirumab plus Irinotecan / Leucovorin / 5-FU versus Ramucirumab plus Paclitaxel in patients with advanced or metastatic adenocarcinoma of… Ended

2024-512934-14-00 advanced or metastatic adenocarcinoma of the stomach or 5 2016-11-07